Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 1:318:160-164.
doi: 10.1016/j.ijcard.2020.06.043. Epub 2020 Jun 28.

COVID-19 trials in Italy: A call for simplicity, top standards and global pooling

Aldo P Maggioni  1 , Felicita Andreotti  2 , Cristina Gervasoni  3 , Giuseppe Di Pasquale  4
Affiliations

COVID-19 trials in Italy: A call for simplicity, top standards and global pooling

Aldo P Maggioni et al. Int J Cardiol. .

Abstract

The novel coronavirus disease, affecting ~9 million people in the past five months and causing >460,000 deaths worldwide, is completely new to mankind. More than 2,000 research projects registered at ClinTrials.gov are aiming at finding effective treatments for rapid transfer to clinical practice. Unfortunately, just few studies have a sufficiently valid design to provide reliable information for clinical practice.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest APM received personal fees from Bayer, Fresenius, Novartis for the participation in study committees outside the present work. FA has received personal fees from Amgen, Bayer, BMS-Pfizer and Daiichi Sankyo outside the present work. GDP has received personal fees for lectures from Boheringer Ingelheim, Bayer, BMS-Pfizer and Daiichi Sankyo outside the present work. CG has received personal fees from MSD, ViiV, Gilead and Janseen Cilag for services outside the present work.

References

    1. Bauchner H., Fontanarosa P.B. Randomized clinical trials and Covid-19: managing expectations. JAMA. 2020 doi: 10.1001/jama.2020.8115. - DOI - PubMed
    1. Glasziou P.P., Sanders S., Hoffmann T. Waste in covid-19 research. BMJ. 2020;369:m1847. doi: 10.1136/bmj.m1847. - DOI - PubMed
    1. Coronavirus drugs trials must get bigger and more collaborative. Nature. 2020;581:120. doi: 10.1038/d41586-020-01391-9. - DOI - PubMed
    1. Eichler H.G., Cavaleri M., Enzmann H. Clinical trials for Covid-19: can we better use the short window of opportunity? [published online ahead of print, 2020 May 14] Clin. Pharmacol. Ther. 2020 doi: 10.1002/cpt.1891. - DOI - PMC - PubMed
    1. Italian Drug Agency 2020. https://www.aifa.gov.it/sperimentazioni-cliniche-covid-19 Accessed June 22.

MeSH terms

Substances